SUN Pharmaceutical Industries Limited Ofloxacin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Ofloxacin Export Records India — #4 Exporter, 202 Shipments, $10.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ofloxacin

India Pharmaceutical Trade Intelligence

$295.2M1,094 Suppliers180 CountriesHS 30049099

ExportsIndia → UNITED STATES39.2%India → VIETNAM6.8%

ImportsMALTA → India$59.6M CHINA → India$17.1M

#1 Buyer: DR REDDYS

SUN Pharmaceutical Industries Limited — Ofloxacin Exporter #4 | $11.2M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Ofloxacin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Ofloxacin · $11.2M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Ofloxacin with $11.2M in export value and 202 verified shipments. SUN Pharmaceutical Industries Limited holds a 3.4% market share in Ofloxacin exports across 20 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Ofloxacin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Ofloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Ofloxacin?

Country	Value	Shipments	Share
RUSSIA	$4.2M	109	34.5%
BELGIUM	$2.4M	145	19.9%
UNITED STATES	$2.3M	46	18.5%
CANADA	$862.0K	25	7.0%
FRANCE

Who Are the Top Buyers of Ofloxacin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
AO RANBAXY	RUSSIA	$3.1M	85
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$2.4M	139
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$1.3M	26
AO "RANBAXY"	RUSSIA	$772.7K	16
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$650.0K	13
TARO PHARMACEUTICALS INC.,	CANADA	$402.0K	9
M S AO RANBAXY	RUSSIA	$400.0K	8
TARO PHARMACEUTICALS INC	CANADA	$300.0K	6
SUN PHARMA ANZ PTY LTD.	AUSTRALIA	$291.0K	20
LLC RANBAXY PHARMACEUTICALS UKRAINE	UKRAINE	$223.0K	6

SUN Pharmaceutical Industries Limited supplies Ofloxacin to 67 buyers globally. The largest buyer is AO RANBAXY (RUSSIA), followed by YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ofloxacin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (	$550.0K	11
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA (BATCH NO AS PER INVOICE)	$373.4K	8
CIPROFLOXACIN 0.3% AND DEXAMETHASONE	$250.0K	5
APO-CIPROFLOXACIN TAB 500mg. EACH FILM C	$174.5K	7
CIPROFLOXACIN TABLETS 500MG ( CIFRAN TAB	$150.0K	3
CIFRAN CT TAB PACK:10S STRIP BATCH:DFE8281A, DFE8359A EACH TAB CONTS. CIPROFLOXACIN HCL EQ TO CIPROFLOXACIN 500MG AND TIPCS	$150.0K	3
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP (FOR CANADA)	$150.0K	3
CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA PACK : 01*01 (BATCH NO AS PER INVO	$150.0K	3
CIFRAN CT TAB PACK : 10S STRIP BATCH : DFE8431A, DFE8432A EACH TAB CONTS CIPROFLOXACIN HCL EQ TO CIPROFLOXACIN 500MG ANPCS	$150.0K	3
CIFRAN CT TAB PACK : 10S STRIP BATCH : DFE8317A, DFE8430A, DFF0019A, DFF0020A EACH TAB CONTS CIPROFLOXACIN HCL EQ TO CIPPCS	$150.0K	3

SUN Pharmaceutical Industries Limited exports 260 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN (0.3%) AND DEXAMETHASONE ( with 11 shipments worth $550.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ofloxacin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	MACLEODS PHARMACEUTICALS LTD	$12.2M	243	33	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$10.1M	202	20	$50.0K
5	MICRO LABS LIMITED	$8.4M	373	33	$22.5K
6	AUROBINDO PHARMA LTD	$7.2M	172	12	$42.0K

SUN Pharmaceutical Industries Limited ranks #4 among 1094 Indian Ofloxacin exporters. Average shipment value of $50.0K compared to the market average of $65.6K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and MICRO LABS LIMITED.

Which Indian Ports Ship Ofloxacin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,841	12.3%
DELHI AIR CARGO ACC (INDEL4)	1,504	10.0%
SAHAR AIR	1,292	8.6%
NHAVA SHEVA SEA (INNSA1)	1,262	8.4%
DELHI AIR	894	6.0%
Bombay Air	655	4.4%
JNPT/ NHAVA SHEVA SEA	645	4.3%
Delhi Air	361	2.4%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ofloxacin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 479 individual customs records matching SUN Pharmaceutical Industries Limited exporting Ofloxacin, covering 260 formulations to 25 countries via 67 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 180+ countries, 3,093+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ofloxacin

Ofloxacin

SUN Pharmaceutical Industries Limited — Ofloxacin Exporter Profile

SUN Pharmaceutical Industries Limited — Ofloxacin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Ofloxacin?

Who Are the Top Buyers of Ofloxacin from SUN Pharmaceutical Industries Limited?

What Is India's Total Ofloxacin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Ofloxacin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Ofloxacin Exporters?

What Ofloxacin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Ofloxacin to Key Markets

United States — FDA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Ofloxacin Exporters?

Which Indian Ports Ship Ofloxacin Exports?

What Other Advanced Antibiotics Products Does SUN Pharmaceutical Industries Limited Export?

Ofloxacin — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Ofloxacin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ofloxacin Export Data from SUN Pharmaceutical Industries Limited

Ofloxacin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source